Keywords: عوارض جانبی ناگهانی درمان; AED; antiepileptic drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; EIAED; enzyme-inducing antiepileptic drug; IGE; idiopathic generalised epilepsy; ILAE; International League Against Epilepsy; TEAE; treatment-emergent adverse event; Ant
مقالات ISI عوارض جانبی ناگهانی درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; AED; antiepileptic drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CBZ; carbamazepine; CYP; cytochrome P450; EIAED; enzyme-inducing antiepileptic drug; LOCF; last observation carried forward; OC; observed case; PB; ph
Keywords: عوارض جانبی ناگهانی درمان; Bronchodilator agents; Electrocardiography; GFF MDI; Pulmonary disease; Chronic obstructive; Holter monitoring; QT prolongation; AE; adverse event; AV; atrioventricular; BID; twice daily; BMI; body mass index; bpm; beats per minute; CI; confidence interva
Keywords: عوارض جانبی ناگهانی درمان; AED; antiepileptic drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CDR; Cognitive Drug Research; COWAT; Controlled Oral Word Association; EIAED; enzyme-inducing antiepileptic drug; IGF-1; insulin-like growth factor-1; LGPT; Lafayette Gr
Keywords: عوارض جانبی ناگهانی درمان; ADT; antidepressant treatment; ANCOVA; analysis of covariance; ATRQ; Massachusetts General Hospital Antidepressant Treatment Response Questionnaire; BMI; body mass index; CGI-I; Clinical Global Impressions - Improvement; DSM-IV-TR; Diagnostic and Statis
Keywords: عوارض جانبی ناگهانی درمان; COPD; Budesonide; Formoterol fumarate dihydrate; Glycopyrronium; Co-suspension delivery technology; Pharmacokinetic; AE; adverse event; AUC0-â; area under the plasma concentration-time curve from time 0 to infinity; AUC0-12; area under the plasma
Keywords: عوارض جانبی ناگهانی درمان; The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
Keywords: عوارض جانبی ناگهانی درمان; Sublingual immunotherapy; Allergic rhinitis; Allergic rhinoconjunctivitis; Asthma; Dosing; AadSS; Average adjusted symptom score; Amb a 1-U; Ambrosia artemisiifolia 1-unit; AR; Allergic rhinitis; ARC; Allergic rhinoconjunctivitis; AUN; Allergy unit native
Keywords: عوارض جانبی ناگهانی درمان; biologic therapy; Crohn's disease; inflammatory bowel disease; interleukin-17 antagonists; ixekizumab; psoriasis; ulcerative colitis; AE; adverse event; CD; Crohn's disease; EPIMAD; Registre Epidemiologique des Maladies de l'Appareil Digestif; IBD; inflam
Keywords: عوارض جانبی ناگهانی درمان; Hereditary angioedema; Bradykinin; C1 inhibitor deficiency; Bradykinin B2 receptor antagonist; Icatibant; Children; Adolescents; Pediatrics; Treatment; AE; adverse event; C1-INH; C1 inhibitor; C1-INH-HAE; hereditary angioedema with C1-inhibitor deficiency
Keywords: عوارض جانبی ناگهانی درمان; ABL-SC; subcutaneous abaloparatide; ACTIVE; Abaloparatide Comparator Trial In Vertebral Endpoints; ACTIVExtend; extension trial of the Abaloparatide Comparator Trial In Vertebral Endpoints; AE; adverse event; ALN; alendronate; BMD; bone mineral density; F
Keywords: عوارض جانبی ناگهانی درمان; Allergen challenge; allergen peptides; allergy; allergic rhinoconjunctivitis; allergic rhinitis; environmental exposure unit; epitope; grass; immunotherapy; synthetic peptide immunoregulatory epitope; AE; Adverse events; AIT; Allergen immunotherapy; ARC;
Keywords: عوارض جانبی ناگهانی درمان; 5-Grass pollen tablet; Grass pollen; Allergic rhinoconjunctivitis; Asthma; Sensitization; Allergy immunotherapy; Allergen-specific immunotherapy; Sublingual immunotherapy; Safety; Clinical trial; AE; Adverse event; ARC; Allergic rhinoconjunctivitis; AIT;
Keywords: عوارض جانبی ناگهانی درمان; clinical trial; cystic fibrosis; exocrine pancreatic insufficiency; pancreatic enzyme-replacement therapy; BMI; Body mass index; CF; Cystic fibrosis; CFA; Coefficient of fat absorption; CNA; Coefficient of nitrogen absorption; EPI; Exocrine pancreatic ins
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; AED; antiepileptic drug; AV; atrioventricular; CV; cardiovascular; ECG; electrocardiogram; PASS; postauthorization safety study; POS; partial-onset seizures; PTSD; posttraumatic stress disorder; SAE; serious adverse event; SS; safety se
Keywords: عوارض جانبی ناگهانی درمان; Focal epilepsy; Quality of life; Seizure freedom; Lacosamide; AED; antiepileptic drug; CGIC; Clinical Global Impression of Change; CPS; complex partial seizures; CS; Completer Set; FAS; Full Analysis Set; LOCF; last observation carried forward; MedDRA; Me
Keywords: عوارض جانبی ناگهانی درمان; Glycated hemoglobin (HbA1c); Body weight; Postprandial plasma glucose (PPG); AE; adverse event; BMI; body mass index; DPP-4; dipeptidyl peptidase-4; FPG; fasting plasma glucose; GI; gastrointestinal; GLP-1; glucagon-like peptide-1; HbA1c; glycated hemoglo
Keywords: عوارض جانبی ناگهانی درمان; Allergic rhinitis; double-blind; placebo-controlled; sublingual immunotherapy tablets; house dust mite; AAdSS; Average Adjusted Symptom Score; AdSS; Adjusted Symptom Score; AIT; Allergen immunotherapy; AR; Allergic rhinitis; ARMS; Average Rescue Medicatio
Keywords: عوارض جانبی ناگهانی درمان; albaconazole; dermatophyte; nail fungus; onychomycosis; phase II study; triazole; AE; adverse event; ECG; electrocardiogram; ITT; intent to treat; KOH; potassium hydroxide; PK; pharmacokinetic; PP; per protocol; SAE; serious adverse event; SD; standard de
Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies
Keywords: عوارض جانبی ناگهانی درمان; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; bid; twice daily; FDA; Food and Drug Administration; OLEx; open-label extension; qam; every morning; qd; once daily; qhs; every night at bedtime; qpm; every evening; SG; secondarily generalized;
Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study
Keywords: عوارض جانبی ناگهانی درمان; Aripiprazole once-monthly; Schizophrenia; Maintenance treatment; Quality of life; AE; adverse event; APTS; all-patients-treated set; AOM 400; aripiprazole once-monthly 400Â mg; CGI-S; Clinical Global Impressions-Severity; C-SSRS; Columbia Suicide Severity
Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease
Keywords: عوارض جانبی ناگهانی درمان; Co-suspension delivery technology; Formoterol fumarate dihydrate; Glycopyrronium; Metered dose inhaler; Spacer; Valved holding chamber; AE; adverse event; ANOVA; analysis of variance; AUC0-12; area under the curve from 0 to 12â¯h; BMI; body mass index;
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
Keywords: عوارض جانبی ناگهانی درمان; ANC; Absolute neutrophil count; AML; Acute myeloid leukemia; BL; Baseline; BM; Bone marrow; CI; Confidence intervals; CMML; Chronic myelomonocytic leukemia; CR; Complete remission; ECOG; Eastern Cooperative Oncology Group; HI; Hematologic improvement; HI-
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study
Keywords: عوارض جانبی ناگهانی درمان; Aripiprazole once-monthly; Long-acting injectable antipsychotic; Maintenance therapy; Bipolar I disorder; AE; adverse event; AIMS; Abnormal Involuntary Movement Scale; AOM 400; aripiprazole once-monthly 400 mg; BARS; Barnes Akathisia Rating Scale; BP-I; b
Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity
Keywords: عوارض جانبی ناگهانی درمان; botulism; botulinum neurotoxin; Human Botulism Immune Globulin; infant botulism; pentavalent botulinum toxoid; recombinant botulinum vaccine; AEs; adverse events; AUC; area under the plasma concentration-time curve; BIG-IV; Human Botulism Immune Globulin
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment
Keywords: عوارض جانبی ناگهانی درمان; immune response; Janus kinase inhibitor; pneumococcal vaccine; T cell; tetanus toxoid; tofacitinib; CI; confidence interval; ELISA; enzyme-linked immunosorbant assay; GMFR; geometric mean fold rise; JAK; Janus kinase; LTE; long-term extension; OPA; opsono
Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany
Keywords: عوارض جانبی ناگهانی درمان; AURA; a retrospective noninterventional study to assess the effectiveness of existing anti-vascular endothelial growth factor treatment regimens in patients with wet age-related macular degeneration; COMPASS; study to assess the efficacy of treatment wi
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; AED; antiepileptic drug; CBZ; carbamazepine; +CBZ; patients who were taking concomitant CBZ; -CBZ; patients who were not taking concomitant CBZ; ESL; eslicarbazepine acetate; FS; focal seizures; LEV; levetiracetam; LCM; lacosamide; LT
Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects
Keywords: عوارض جانبی ناگهانی درمان; GFF MDI; Chronic obstructive pulmonary disease; Co-suspension delivery technology; LAMA/LABA; Pharmacokinetics; AE; adverse event; AUC0-12; area under the curve from 0 to 12â¯h; AUC0-t; area under the curve from 0 to time of the last measurable plasm
Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial
Keywords: عوارض جانبی ناگهانی درمان; α-adrenergic receptors; β-adrenergic receptors; facial dermatoses; skin abnormalities; vascular skin diseases; vasoconstrictor agents; AE; adverse event; CEA; Clinician Erythema Assessment; CTA; Clinician Telangiectasia Assessment; SSA; Subject Self-Ass
Safety and pharmacokinetics of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (BGF MDI) in healthy adult subjects of Japanese descent
Keywords: عوارض جانبی ناگهانی درمان; Chronic obstructive pulmonary disease; Co-suspension delivery technology; ICS/LAMA/LABA; Western; Japanese; Triple fixed-dose combination; AE; adverse event; AUC0-12; area under the plasma concentration-time curve from 0 to 12â¯h; AUC0-â; area un
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48Â weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)
Keywords: عوارض جانبی ناگهانی درمان; anti-TNF; anti-tumor necrosis factor; certolizumab pegol; chronic plaque psoriasis; CIMPASI-1; CIMPASI-2; phase 3 trial; CZP; certolizumab pegol; DLQI; Dermatology Life Quality Index; FcRn; neonatal Fc receptor; PASI; Psoriasis Area and Severity Index;
Novel 1 L polyethylene glycol-based bowel preparation NER1006 for overall and right-sided colon cleansing: a randomized controlled phase 3 trial versus trisulfate
Keywords: عوارض جانبی ناگهانی درمان; ADR; adenoma detection rate; BBPS; Boston Bowel Preparation Scale; BOCLIR; Bowel Cleansing Impact Review; CL; confidence limit; CRC; colorectal cancer; FAS; full analysis set; GFR; glomerular filtration rate; HCS; Harefield Cleansing Scale; LCL; lower con
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48Â weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)
Keywords: عوارض جانبی ناگهانی درمان; anti-TNF; anti-tumor necrosis factor; certolizumab pegol; chronic plaque psoriasis; CIMPACT; etanercept; phase 3 trial; CZP; certolizumab pegol; FcRn; neonatal Fc receptor; PASI; Psoriasis Area and Severity Index; PASI 50; â¥50% reduction in PASI from
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Keywords: عوارض جانبی ناگهانی درمان; anti-IL-17; anti-IL-17A; anti-IL-17F; bimekizumab; biologic therapy; clear or almost clear skin; dose ranging; efficacy; interleukin 17A; interleukin 17F; PASI90; PASI100; phase 2b; plaque psoriasis; randomized clinical trial; safety; AE; adverse event; I
Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
Keywords: عوارض جانبی ناگهانی درمان; Cirrhosis; Coagulation; Thrombopoietin Receptor Agonist; Thrombosis; AE; adverse event; AESI; adverse event of special interest; CLD; chronic liver disease; MELD; Model for End-Stage Liver Disease; TEAE; treatment-emergent adverse event;
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Keywords: عوارض جانبی ناگهانی درمان; Combined Remission; Clinical Remission; Anal Fistula; Cell Therapy; CDAI; Crohn's Disease Activity Index; CI; confidence interval; Cx601; allogeneic; expanded; adipose-derived stem cells; IBDQ; inflammatory bowel disease questionnaire; LOCF; last observ
A phase 1 study to evaluate the safety and pharmacokinetics of MEDI8852, an anti-influenza A monoclonal antibody, in healthy adult volunteers
Keywords: عوارض جانبی ناگهانی درمان; MEDI8852; Monoclonal antibody; Influenza; Hemagglutinin; ADA; anti-drug antibodies; AUC0-t; area under the concentrationâtime curve from time 0 to last sampling time point; AUCâ; area under the plasma concentrationâtime curve from time 0 to infinity
Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study
Keywords: عوارض جانبی ناگهانی درمان; AED; antiepileptic drug; CNS; central nervous system; ELDQOL; Epilepsy and Learning Disabilities Quality of Life scale; LGS; Lennox-Gastaut Syndrome; QoL; quality of life; SD; standard deviation; TEAE; treatment-emergent adverse event; VABS-II; Vineland
Lifitegrast for the Treatment of Dry Eye Disease
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; CI; confidence interval; DCS; drop comfort score; DED; dry eye disease; EDS; eye dryness score; ICSS; inferior corneal staining score; ITT; intention-to-treat; ODS; ocular discomfort score; SD; standard deviation; TE; treatment effect;
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; BCVA; best-corrected visual acuity; CI; confidence interval; CME; cystoid macular edema; CSMT; central subfield macular thickness; EMA CHMP; European Medicines Agency Committee for Medicinal Products for Human Use; FAS; full analysis se
Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CNV; choroidal neovascularization; CST; central subfield thickness; FcRn; neonatal Fc receptor; IgG; immunoglobulin G; IOP; intraocular pressure; MD; multiple do
Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; BPD; bronchopulmonary dysplasia; GA; gestational age; IGF-1; insulin-like growth factor-1; IGFBP-3; insulin-like growth factor binding protein-3; IV; intravenous; IVH; intraventricular hemorrhage; MedDRA; Medical Dictionary for Regulato
Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; AED; antiepileptic drug; CBZ; carbamazepine; C-SSRS; Columbia Suicide Severity Rating Scale; CYP450; cytochrome P450; fT4; free thyroxine; HDL; high-density lipoprotein; LDL; low-density lipoprotein; LEV; levetiracetam; SHBG; sex-hormon
Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis
Keywords: عوارض جانبی ناگهانی درمان; Antiepileptic drugs; Perampanel; Concomitant; Enzyme-inducing; Efficacy; AED; antiepileptic drug; ANCOVA; analysis of covariance; BMI; body mass index; CI; confidence interval; CNS; central nervous system; SAE; serious adverse event; TEAE; treatment-emerg
A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA
Keywords: عوارض جانبی ناگهانی درمان; AE; adverse event; BSID-III; Bayley Scales of Infant and Toddler Development, Third Edition; CSF; cerebrospinal fluid; CNS; central nervous system; DQ; developmental quotient; EC; Enzyme Commission; ELISA; enzyme-linked immunosorbent assay; GAG; glycosami
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial
Keywords: عوارض جانبی ناگهانی درمان; doxycycline; erlotinib; folliculitis; non-small-cell lung cancer; rash; AE; adverse event; CI; confidence interval; CONSORT; CONsolidated Standards Of Reporting Trials; CTCAE; Common Terminology Criteria for Adverse Events; CYTAR; CYcline and TARceva; DI;
Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis
Keywords: عوارض جانبی ناگهانی درمان; Phosphatidylinositol 3-kinase; p110δ; grass pollen; allergen challenge chamber; Vienna Challenge Chamber; idelalisib; GS-1101; CCL17; CCL22; allergic rhinitis; TEAE; Treatment-emergent adverse event; TNNSS; Total nonnasal symptom score; TNSS; Total nasal
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study
Keywords: عوارض جانبی ناگهانی درمان; Lennox-Gastaut syndrome; Rufinamide; Antiepileptic drug therapy; Randomized study; Pharmacokinetic; safety; Infants; AED; antiepileptic drug; AUC; area under the concentration-time curve; Cav; steady-state exposure; CI; confidence interval; CL/F; appare
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma
Keywords: عوارض جانبی ناگهانی درمان; Asthma; roflumilast; montelukast; phosphodiesterase 4 inhibitors; ACQ; Asthma Control Questionnaire; AE; Adverse event; ANCOVA; Analysis of covariance; ATS; American Thoracic Society; BMI; Body mass index; COPD; Chronic obstructive pulmonary disease; C-SS